New drugs and clinical trial rules 2019, what is new? our views from ethical perspective

Shivaprakash, G and Pallavi, LC (2019) New drugs and clinical trial rules 2019, what is new? our views from ethical perspective. Journal of The Association of Physicians of India, 67 (10). pp. 75-76. ISSN 0004-5772

[img] PDF
RMS - 00007504.pdf - Published Version
Restricted to Registered users only

Download (129kB) | Request a copy

Abstract

A good quality research requires the incorporation of good ethical practices throughout the conduct of the study. An efficient Ethics Committee will facilitate such a research at the site, and can achieve the major objective of ICH-GCP (International Conference on Harmonisation -Good Clinical Practice) guidelines. Awareness of the changing rules among the stakeholders of clinical studies will ensure good clinical practice by safeguarding and protecting the rights, safety and well-being of the research participants. The draft of the New Drugs and Clinical Trials Rules was published in the Gazette of India by central government on March 19, 2019. Keeping abreast of the latest rules are essential for the uninterrupted conduct of clinical studies. We sought to give a summary of important changes in the new rules and to assess those rules from ethical perspective.

Item Type: Article
Subjects: Medicine > KMC Manipal > Pharmacology
Medicine > KMC Manipal > Physiology
Depositing User: KMC Library
Date Deposited: 01 Jul 2020 08:46
Last Modified: 01 Jul 2020 08:46
URI: http://eprints.manipal.edu/id/eprint/155167

Actions (login required)

View Item View Item